Effects of Eszopiclone on Sleep and Memory in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Schizophrenia
Interventions
DRUG

eszopiclone

3 mg of eszopiclone for two consecutive nights (Baseline Night and Experimental Night). Sleep spindle density (primary outcome) is measured for both nights. Memory consolidation (secondary outcome) is measured over Experimental Night.

DRUG

placebo

placebo capsule for two consecutive nights. (Baseline Night and Experimental Night). Sleep spindle density (primary outcome) is measured for both nights. Memory consolidation (secondary outcome) is measured over Experimental Night.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Mclean Hospital

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01641900 - Effects of Eszopiclone on Sleep and Memory in Schizophrenia | Biotech Hunter | Biotech Hunter